Wednesday October 29, 2008 (foodconsumer.org) — A new Korean study published on Oct 9 in Archives of Toxicology suggests that ingestion of bisphenol A or BPA may not increase risk of breast cancer.
The study led by Yang M at Sookmyung Women’s University in Seoul, Republic of Korea found there was no significant difference in blood BPA levels between the breast cancer patients and women without the disease.
The National Cancer Institute has announced its decision to suspend a study on the benefits of vitamin E and selenium supplements treatments on prostate cancer prevention. The study, called SELECT (Selenium and vitamin E Cancer Prevention Trial), involved more than 35,000 men and was conducted at 400 sites around the United States.
Researchers found a higher risk for aggressive prostate cancer in participants taking only vitamin E and a small increased risk of developing diabetes in subjects taking only selenium. The researchers cautioned that those effects may have been due to chance and they were not statistically significant.
Testosterone, the male sex hormone, boosts sexual desire and activities in postmenopausal women, according to a recent study. But a small review published earlier said the effect of the male hormone therapy on the risk of breast cancer remains uncertain.
Off-label use of testosterone is allowed in the United States although the FDA has not approved this treatment for low sexual function or hypoactive sexual desire disorder particularly in postmenopausal women who experience surgery induced menopause.
WASHINGTON - Women who take hormone replacement therapy to treat menopause symptoms do not have a higher than usual risk of heart attack, especially if they use a cream or skin patch or take cyclic hormone combinations, Danish researchers reported yesterday.
Their study, published in the European Heart Journal, suggests it is not hormone replacement therapy that raises the risk of heart attacks in women, but the way it is taken.
It also shows that the Women’s Health Initiative, which frightened many women away from HRT after it was stopped in 2002, may not be the last word on treatment.
Thursday October 16, 2008 (foodconsumer.org) — In the National Breast Cancer Awareness Month, you may do something to help yourselves reduce the risk of breast cancer. But first, equip yourselves with current knowledge about how to prevent the disease.
We have published quite a few articles on breast cancer prevention because it is better for women to prevent the disease from developing in the first place than to get treated after contracting the disease.
Wednesday October 29, 2008 (foodconsumer.org) — A new Korean study published on Oct 9 in Archives of Toxicology suggests that ingestion of bisphenol A or BPA may not increase risk of breast cancer.
The study led by Yang M at Sookmyung Women’s University in Seoul, Republic of Korea found there was no significant difference in blood BPA levels between the breast cancer patients and women without the disease.
Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, according to a new study published in the British Journal of Cancer.
Half of the women failed to finish a five year course of the drug and one in five regularly forget to take a tablet.
Experts already know that taking tamoxifen for five years increases survival chances and the new research reveals that women who miss at least one tablet every five days have a 10 per cent greater risk of dying.
Read the rest of this entry »NEW YORK (Reuters Health) - Data from the Women’s Health Initiative Observational Study show that higher than normal insulin levels are an independent risk factor for breast cancer.
Study investigators, led by Dr. Marc J. Gunter at Albert Einstein College of Medicine in the Bronx, New York, examined the association between breast cancer and blood parameters at study entry in 835 women who later developed breast cancer and 816 who did not. All of the women were postmenopausal and none were diabetic at baseline.